Keiji Oishi
Yamaguchi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 75 publications
EOSINOPHIL-ASSOCIATED DISEASES: A PATHOBIOLOGY-BASED, CROSS-ORGAN PERSPECTIVE
Journal: Arerugi = [Allergy]
Published: June 10, 2026
Novel Frailty Assessment Based on Multidimensional Physical Frailty Parameters Using Unsupervised Clustering in Respiratory Diseases: A Pilot Study.
Journal: Journal of clinical medicine
Published: May 12, 2026
Diversity of Factors Associated with Physical Inactivity in Patients with Asthma Based on Activity Intensity.
Journal: Journal of clinical medicine
Published: April 21, 2026
A Case of Methotrexate-induced Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder with Diffuse Ground-glass Opacities Diagnosed Using a Cryobiopsy.
Journal: Internal medicine (Tokyo, Japan)
Published: March 18, 2026
A prospective, multicenter cohort study to identify unmet medical needs in Japanese patients with chronic obstructive pulmonary disease: The J-UNMET-COPD study protocol.
Journal: Respiratory investigation
Published: January 16, 2026
One-year clinical remission with tezepelumab in severe asthma: TERESA single-arm prospective study.
Journal: The Journal of allergy and clinical immunology
Published: December 16, 2025
Small RNA Profiles of Serum-Derived Extracellular Vesicles in the Comorbid Condition of Frailty and Obstructive Pulmonary Disease: An Observational, Cross-Sectional Study.
Journal: Biomolecules
Published: October 21, 2025
Integration of patient-reported outcomes and myokine profiling for the detection of physical inactivity in COPD: an exploratory multicentre study.
Journal: Scientific reports
Published: October 02, 2025
Secondary Pulmonary Alveolar Proteinosis Associated With Ruxolitinib After Bone-Marrow Transplantation: A Case With Transient Improvement Following Drug Discontinuation.
Journal: Respirology case reports
Published: September 08, 2025
Fractional exhaled nitric oxide as a biomarker for the evaluating asthmatic patients with allergic bronchopulmonary mycosis.
Journal: Respiratory investigation
Published: June 19, 2025
Pamufetinib (TAS-115) for chronic fibrosing interstitial lung diseases with a progressive phenotype: a double-blind, multicenter, phase 2b clinical trial.
Journal: American journal of respiratory and critical care medicine
Published: June 13, 2025
Impact of Frailty on Major Adverse Cardiovascular Events in Chronic Obstructive Pulmonary Disease.
Journal: International journal of chronic obstructive pulmonary disease
Published: May 19, 2025
Last Updated: 09/26/2026